COVID-19: Cambridge vaccine gets £1.9 million to begin clinical trials

August 26, 2020 THE COVID REMEDY

The funding of £1.9 million will allow the team to take the vaccine candidate to clinical trial at the University Hospital Southampton NHS Foundation …

Source: COVID-19: Cambridge vaccine gets £1.9 million to begin clinical trials

← TYME's Oncology Research Reveals Potential New Oral Therapy TYME-19 in the Fight Against …
Celltrion to begin P1 trial of antibody-drug on mild Covid-19 patients →